Trio of scientists who urged stockpiling had previously been paid, says Council of Europe report bemoaning tentacles of drug company influenceScientists who drew up the key World Health Organisation guidelines advising governments to stockpile drugs in the event of a flu pandemic had previously been paid by drug companies which stood to profit, according to a report out today.An investigation by the British Medical Journal and the Bureau of Investigative Journalism, the not-for-profit reporting unit, shows that WHO guidance issued in 2004 was authored by three scientists who had previously received payment for other work from Roche, which makes Tamiflu, and GlaxoSmithKline (GSK), manufacturer of Relenza.City analysts say that pharmaceutical companies banked more than $7bn (£4.8bn) as governments stockpiled drugs. The issue of transparency has risen to the forefront of public health debate after dramatic predictions last year about a swine flu pandemic did not come true.Some countries, notably Poland,...
- Using a small stockpile of a secondary antiviral drug in a flu pandemicThu, 30 Apr 2009, 14:39:11 EDT
- Is it right for drug companies to carry out their own clinical trials?Mon, 30 Nov 2009, 14:58:23 EST
- Pandemic flu, like seasonal H1N1, shows signs of resisting TamifluMon, 1 Mar 2010, 12:51:51 EST
- Blood pressure killing the world's workers while banks and drug firms stand idleFri, 2 May 2008, 11:49:15 EDT
- Swine flu patients benefited from taking Tamiflu, says studyWed, 29 Sep 2010, 5:15:57 EDT